outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * requires intervention to prevent permanent impairment or damage A 51-year-old man developed hypoglycaemia following intentional ingestion of insulin aspart, insulin glargine, and insulin lispro in a suicide ...
OBJECTIVE—Both rapid-acting insulin analogs, insulin aspart and lispro, attenuate prandial glucose excursion compared with human soluble insulin. This tri... J Plank,A Wutte,G Brunner,... - 《Diabetes Care》 被引量: 235发表: 2002年 Randomized, multinational, open-label, 2-period, crossover ...
ninsulina;basal —insulina basal;human —insulina humana;— analogueanálogo de la insulina;— aspartinsulina aspart, insulina asparta (INN);— detemirinsulina detemir;— glargineinsulina glargina;— gluli-sineinsulina glulisina;— lisproinsulina lispro;intermediate-acting —insulina de acción...
When insulin lispro and insulin aspart were compared in a single-blind, randomized, crossover study in 14 patients with type 1 diabetes, insulin lispro had a faster onset of action but a shorter duration (11). However, in another study the pharmacokinetic and the pharmacodynamic profiles of ins...
Aspart and lispro insulin, is there any difference when used with an insulin pump treatment?Continuous subcutaneous insulin infusionInsulin pumpInsulin analoguesType 1 diabetesHbAlcThe DCC and the EDIC study studies showed the significance of intensive insulin treatment in reducing blood glucose levels ...
Insulin/insulin glargine/insulin lispro Reactions Weekly - None - 《Reactions Weekly》 被引量: 0发表: 2016年 Insulin/insulin aspart/insulin glargine/insulin lispro Reactions Weekly - None - 《Reactions Weekly》 被引量: 0发表: 2014年 A 16-week comparison of the novel insulin analog insulin ...
OBJECTIVE To compare the safety and efficacy of insulin aspart (IAsp), buffered regular insulin (BR), and insulin lispro administered by continuous subcutaneous insulin infusion (CSII) in patients with type 1 diabetes.RESEARCH DESIGN AND METHODS After completing a 4-week run-in period with BR, ...
Novolog (the brand name for insulin aspart) lasts 3 to 5 hours. Novolog is a rapid-acting insulin. It begins working in as little as 10 minutes and reaches peak effectiveness in 40 to 50 minutes. Which insulin is best? No form of insulin is best. Each category of insulin has unique...
The more recent faster-acting mealtime insulins, namely faster aspart (NovoNordisk), ultra-rapid lispro (Eli Lilly), and Biochaperone lispro (Adocia), benefit from added excipients that increase subcutaneous blood flow and/or vascular permeability to speed up absorption and by the inclusion of the...
Retail prices for generic insulin lispro, insulin aspart, and insulin glargine are currently about two-thirds that of Humalog, Novolog, and Lantus, respectively. The same goes for the generic mixed insulins, insulin lispro 75/25 and insulin aspart 70/30, and their counterparts, Humalog 75/25...